Comparing the Efficacy of Biosimilar UJVIRA With That of T-DM1 in HER2-Positive Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Breast Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic Breast Cancer: A Randomized, Open-Label, Multicenter Study in India
Clin. Breast Cancer 2021 Nov 27;[EPub Ahead of Print], S Chiradoni Thungappa, T Maksud, N Raut, R Nagarkar, U Batra, S Kumar, D ParmarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.